journal article·2018-12-01

Surface-grafted antimicrobial drugs: Possible misinterpretation of mechanism of action

Javad Naderi, Carla Giles, Solmaz Saboohi, Hans J. Griesser, Bryan R. Coad

Biointerphases· Volume 13· Issue 6
Publisher page

Abstract

Antimicrobial surface coatings that act through a contact-killing mechanism (not diffusive release) could offer many advantages to the design of medical device coatings that prevent microbial colonization and infections. However, as the authors show here, to prevent arriving at an incorrect conclusion about their mechanism of action, it is essential to employ thorough washing protocols validated by surface analytical data. Antimicrobial surface coatings were fabricated by covalently attaching polyene antifungal drugs to surface coatings. Thorough washing (often considered to be sufficient to remove noncovalently attached molecules) was used after immobilization and produced samples that showed a strong antifungal effect, with a log 6 reduction in Candida albicans colony forming units. However, when an additional washing step using surfactants and warmed solutions was used, more firmly adsorbed compounds were eluted from the surface as evidenced by XPS and ToF-SIMS, resulting in reduction and complete elimination of in vitro antifungal activity. Thus, polyene molecules covalently attached to surfaces appear not to have a contact-killing effect, probably because they fail to reach their membrane target. Without additional stringent washing and surface analysis, the initial favorable antimicrobial testing results could have been misinterpreted as evidencing activity of covalently grafted polyenes, while in reality activity arose from desorbing physisorbed molecules. To avoid unintentional confirmation bias, they suggest that binding and washing protocols be analytically verified by qualitative/quantitative instrumental methods, rather than relying on false assumptions of the rigors of washing/soaking protocols.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antifungal resistance and susceptibility · Antimicrobial agents and applications · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Future Industries Institute, University of South Australia 1 , Adelaide 5000, Australia

Department of Primary Industries Parks Water and Environment Tasmania, Centre for Aquatic Animal Health and Vaccines 2 , 165 Westbury Road, Prospect, Tasmania 7250, Australia

School of Agriculture, Food and Wine, University of Adelaide 3 , Adelaide 5000, Australia

Funding

Australian Research Council

References (41)

Show source-provided references
1. Biomaterials · 2013 · 34 · 853310.1016/j.biomaterials.2013.07.089 ↗
2. Biotechnol Adv. · 2018 · 36 · 26410.1016/j.biotechadv.2017.11.010 ↗
3. 2017
4. Curr. Med. Chem. · 2015 · 22 · 211610.2174/0929867321666140916121355 ↗
5. 2012
6. J. Mater. Chem. · 2009 · 19 · 779610.1039/b905668h ↗
7. PLoS Pathog. · 2016 · 12 · e100559810.1371/journal.ppat.1005598 ↗
8. J. Mater. Chem. B · 2015 · 3 · 846910.1039/C5TB00961H ↗
9. Biointerphases · 2011 · 6 · CL210.1116/1.3645195 ↗
10. Clin. Microbiol. Rev. · 2007 · 20 · 13310.1128/CMR.00029-06 ↗
11. FEMS Yeast Res. · 2006 · 6 · 97910.1111/j.1567-1364.2006.00117.x ↗
12. Seneviratne · 2017 · 49
13. Nat. Rev. Microbiol. · 2010 · 8 · 34010.1038/nrmicro2313 ↗
14. Biotechnol. Adv. · 2014 · 32 · 29610.1016/j.biotechadv.2013.10.015 ↗
15. Mayo Clin. Proc. · 2011 · 86 · 80510.4065/mcp.2011.0247 ↗
16. Antimicrob. Agents Chemother. · 1990 · 34 · 18310.1128/AAC.34.2.183 ↗
17. Trends Pharmacol. Sci. · 1996 · 17 · 44510.1016/S0165-6147(96)01012-7 ↗
18. Biomacromolecules · 2010 · 11 · 281010.1021/bm100893r ↗
19. Int. J. Nanomed. · 2007 · 2 · 301
20. Angew. Chem. Int. Ed. Engl. · 2005 · 44 · 635810.1002/anie.200501613 ↗
21. Pharm. Sci. Technol. Today · 2000 · 3 · 16310.1016/S1461-5347(00)00255-8 ↗
22. Pharm. Res. · 2007 · 24 · 97110.1007/s11095-006-9222-z ↗
23. Org. Biomol. Chem. · 2007 · 5 · 133910.1039/b701953j ↗
24. Mini-Rev. Med. Chem. · 2009 · 9 · 130610.2174/138955709789878178 ↗
25. ACS Nano · 2011 · 5 · 19910.1021/nn1023522 ↗
26. Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 1299410.1073/pnas.0705250104 ↗
27. Vacuum · 1989 · 39 · 48510.1016/0042-207X(89)90272-8 ↗
28. 1998
29. Riviere · 2009 · 52910.1201/9781420007800 ↗
30. Biointerphases · 2017 · 12 · 05G60210.1116/1.4986054 ↗
31. 2013 · 259
32. Langmuir · 2012 · 28 · 271010.1021/la204714p ↗
34. Biointerphases · 2015 · 10 · 04A31010.1116/1.4937464 ↗
35. Biointerphases · 2012 · 7 · 4910.1007/s13758-012-0049-3 ↗
36. Proc. Natl. Acad. Sci. U.S.A. · 2012 · 109 · 223410.1073/pnas.1117280109 ↗
37. 2016
38. 2011
39. Biointerphases · 2015 · 10 · 04A30710.1116/1.4933108 ↗
40. Biointerphases · 2017 · 12 · 02C30110.1116/1.4982169 ↗
41. J. Antibiot. · 1985 · 38 · 75310.7164/antibiotics.38.753 ↗